About Neuronetics
Neuronetics is a company based in Malvern (United States) founded in 2001. Neuronetics has raised $177.8 million across 8 funding rounds from investors including General Electric, New Leaf Venture Partners and Ascension Ventures. The company has 167 employees as of December 31, 2022. Neuronetics offers products and services including NeuroStar Advanced Therapy System. Neuronetics operates in a competitive market with competitors including Muse, Flow Neuroscience, Freespira, Sooma Oy and HypnoVR, among others.
- Headquarter Malvern, United States
- Employees 167 as on 31 Dec, 2022
-
Sectors
TechnologyHealthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Neuronetics, Inc.
-
Annual Revenue
$15.27 M (USD)2327as on Dec 31, 2024
-
Net Profit
-$19 K (USD)100as on Dec 31, 2024
-
EBITDA
-$34.56 M (USD)-13as on Dec 31, 2024
-
Total Equity Funding
$177.8 M (USD)
in 8 rounds
-
Latest Funding Round
$15 M (USD), Series G
Jun 06, 2017
-
Investors
General Electric
& 14 more
-
Employee Count
167
as on Dec 31, 2022
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Neuronetics
Neuronetics offers a comprehensive portfolio of products and services, including NeuroStar Advanced Therapy System.
Non-invasive TMS treatment for depression and comorbid anxiety symptoms.
Funding Insights of Neuronetics
Neuronetics has successfully raised a total of $177.8M across 8 strategic funding rounds. The most recent funding activity was a Series G round of $15 million completed in June 2017. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Neuronetics
Neuronetics has secured backing from 15 investors, including venture fund and institutional investors. Prominent investors backing the company include General Electric, New Leaf Venture Partners and Ascension Ventures.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Strategic investments in healthcare technologies and data innovations.
|
Locked | Locked | Locked | |
|
Early-stage US healthcare investments are made by Accuitive Medical Ventures.
|
Locked | Locked | Locked | |
|
Early-stage investing in IT and healthcare ventures.
|
Locked | Locked | Locked |
Investor details for Neuronetics
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Neuronetics
Investment portfolio details for Neuronetics
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Neuronetics
Detailed financials for Neuronetics
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Neuronetics Comparisons
Peer comparison for Neuronetics
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Neuronetics
Neuronetics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Muse, Flow Neuroscience, Freespira, Sooma Oy and HypnoVR, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
EEG-powered headbands for meditation and sleep biofeedback are developed.
|
|
| Locked | Locked | Locked |
Provider of a wearable device for stress and anxiety management
|
|
| Locked | Locked | Locked |
Panic disorders are treated via breathing device and mobile app.
|
|
| Locked | Locked | Locked |
Non-invasive neuromodulation therapies
|
|
| Locked | Locked | Locked |
Virtual reality therapies for pain and anxiety reduction are developed.
|
|
| Locked | Locked | Locked |
Provider of digital Precision Medicine company leveraging objective data and passive measurement for mental healthcare
|
Detailed competitors of Neuronetics
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Neuronetics
Complete news archive for Neuronetics
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Neuronetics
Neuronetics was founded in 2001.
Neuronetics is headquartered in Malvern, United States. It is registered at Malvern, Pennsylvania, United States.
Neuronetics is a funded company, having raised a total of $177.8M across 8 funding rounds to date.
As of Dec 31, 2022, the latest employee count at Neuronetics is 167.
Annual revenue of Neuronetics is $15.27M as on Dec 31, 2024.
Neuronetics, Inc. was founded in 2001 by The Innovation Factory in Atlanta and is headquartered in Malvern, United States. Non-invasive therapies for psychiatric and neurological disorders are developed using MRI-strength magnetic field pulses. A depression treatment, non-systemic and non-invasive, has been cleared by the FDA for patients unresponsive to prior antidepressants. Operations center on medical device innovation within the healthcare sector, targeting unmet needs in mental health.
Neuronetics's top competitors include Muse, Flow Neuroscience and Freespira.
Neuronetics offers NeuroStar Advanced Therapy System.
Neuronetics has 15 investors. Key investors include General Electric, New Leaf Venture Partners, Ascension Ventures, Accuitive Medical Ventures, and InterWest.